Menu
Washingtoner
  • Home
  • Health
  • Technology
  • Books
  • Business
  • Artificial Intelligence
  • Lifestyle
  • Aerospace
  • Marketing
Washingtoner

SafeBreak® Vascular Cleared for Pediatrics
Washingtoner/10219541

Trending...
  • City of Spokane Launches New Webpage, Notice Document to Connect Residents with Eviction Prevention Resources
  • City of Tacoma Attracts More Affordable Housing to Proctor Neighborhood
  • Tacoma: Homicide Investigation – 800 Block of Martin Luther King JR Way
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - Washingtoner -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on Washingtoner
  • Boston Industrial Solutions Introduces New Natron® 310 Hyper White UV Ink for Enhanced Printing Performance
  • New Tribute Song Celebrating Seattle'
  • New analysis reveals second job workers keep just 80p in every pound they earn
  • NRE Health Institute Launches International Study Examining Motivations Behind Non-Sexual Nudity
  • A Foundational Claim in Human Secrecy Goes Public

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • From Broken to Soaring Week 40
  • Tacoma Dome Welcomes Class of 2026
  • Finnish Political Satire Film Generates 10,000+ Cross-Platform Interactions Following Gandalf Parody Video Across TikTok, YouTube and Telegram
  • City of Tacoma Launches 'Tidy-Up Tacoma: Summer 2026' With Major Gateway Cleanup Effort
  • Grady Bay Capital Completes Acquisition of Brickhouse GPS
  • AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
  • 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
  • netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
  • Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent
  • Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
  • City of Tacoma Attracts More Affordable Housing to Proctor Neighborhood
  • Tacoma: Homicide Investigation – 800 Block of Martin Luther King JR Way
  • Spokane: Community Days At City Council Celebrating Student Civic Engagement
  • Boston Industrial Solutions Launches Natron® 348 UV Inkjet Ink for Epson S3200 Print Heads
  • Heritage at South Brunswick Unveils Luxury Resort-Style Amenities Designed for Every Generation
  • Spokane: Working Smoke Alarms Help Seven Escape Early-Morning House Fire
  • CAPHRA warns push for ASEAN vape ban ignores science
  • Spokane: Egypt National Team to Hold Open Training Session at Gonzaga University Ahead of FIFA World Cup 2026™
_catLbl0 _catLbl1

Popular on Washingtoner

  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan - 170
  • Applicants Sought for the Tacoma Creates Advisory Board - 114
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
  • KLEKT Announces Appointment of Jay Kimpton to Board of Directors
  • Spokane: Flags Lowered for Peace Officers Memorial Day
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • As Pentagon Releases Ufo Files, Debut Ya Novel Predicted It All
  • Spokane Police are investigating a collision on West Airport Drive
  • Andrew Tate Says Los Angeles Is "Where I Belong" as He Hints at USA Move

Similar on Washingtoner

  • ATTENTION: DGCA India & CAAC China — Boeing Quality Chief Doug Ackerman Linked To 24 Year Unaccredited Manufacturing Gap Ahead Of 787 Failures
  • CCHR Calls Out Psychiatry's Pattern of Resistance to Antidepressant Deprescribing
  • NRE Health Institute Launches International Study Examining Motivations Behind Non-Sexual Nudity
  • A Foundational Claim in Human Secrecy Goes Public
  • AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
  • netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
  • Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
  • Boston Industrial Solutions Launches Natron® 348 UV Inkjet Ink for Epson S3200 Print Heads
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute